Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Human immune and gut microbial parameters associated with inter-individual variations in COVID-19 mRNA vaccine-induced immunity
Masato Hirota, Miho Tamai, Sachie Yukawa, et al.
Communications Biology (2023) Vol. 6, Iss. 1
Open Access | Times Cited: 12

Showing 12 citing articles:

Gut Microbiota Dysbiosis in COVID-19: Modulation and Approaches for Prevention and Therapy
Virna Margarita Martín Giménez, Javier Modrego, Dulcenombre Gómez‐Garré, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 15, pp. 12249-12249
Open Access | Times Cited: 18
Stability of gut microbiome after COVID-19 vaccination in healthy and immuno-compromised individuals
Rebecca H. Boston, Rui Guan, Lajos Kalmár, et al.
Life Science Alliance (2024) Vol. 7, Iss. 4, pp. e202302529-e202302529
Open Access | Times Cited: 3
Precision Vaccinology Approaches for the Development of Adjuvanted Vaccines Targeted to Distinct Vulnerable Populations
Branden Lee, Etsuro Nanishi, Ofer Levy, et al.
Pharmaceutics (2023) Vol. 15, Iss. 6, pp. 1766-1766
Open Access | Times Cited: 7
The role of the gut microbiota in regulating responses to vaccination: current knowledge and future directions
Charné Rossouw, Feargal J. Ryan, David J. Lynn
FEBS Journal (2024)
Open Access | Times Cited: 1
B and T cell responses to the BNT162b2 COVID-19 mRNA vaccine are not impaired in germ-free or antibiotic-treated mice
Todd S. Norton, Miriam A. Lynn, Charné Rossouw, et al.
Gut (2023) Vol. 73, Iss. 7, pp. 1222-1224
Open Access | Times Cited: 3
COVID-19-Omics Report: From Individual Omics Approaches to Precision Medicine
Irina Vlasova-St. Louis, Daniel Fang, Yara Amer, et al.
Reports — Medical Cases Images and Videos (2023) Vol. 6, Iss. 4, pp. 45-45
Open Access | Times Cited: 3
Gut microbiome remains stable following COVID-19 vaccination in healthy and immuno-compromised individuals
Rebecca H. Boston, Rui Guan, Lajos Kalmár, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 2
Systematic review of the impact of intestinal microbiota on vaccine responses
Cristina Ardura‐Garcia, Nigel Curtis, Petra Zimmermann
npj Vaccines (2024) Vol. 9, Iss. 1
Open Access
Cellular and molecular insights into the individual difference in COVID-19 mRNA vaccine responses
Hiroki ISHIKAWA, Masato Hirota, Miho Tamai
Translational and Regulatory Sciences (2024) Vol. 6, Iss. 1, pp. 15-19
Open Access
Development of chimeric MrNV virus-like particles capable of binding to SARS-CoV-2-susceptible cells and reducing infection by pseudovirus variants
Supawich Boonkua, Orawan Thongsum, Purimpuch Soongnart, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access
COVID-19 mRNA vaccine-mediated antibodies in human breast milk and their association with breast milk microbiota composition
Shilin Zhao, Kris Yuet Wan Lok, Zhen Ye Sin, et al.
npj Vaccines (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 1
Vaccination with an HIV T-Cell Immunogen (HTI) Using DNA Primes Followed by a ChAdOx1-MVA Boost Is Immunogenic in Gut Microbiota-Depleted Mice despite Low IL-22 Serum Levels
Aleix Elizalde‐Torrent, Alessandra Borgognone, María Casadellà, et al.
Vaccines (2023) Vol. 11, Iss. 11, pp. 1663-1663
Open Access
Page 1

Scroll to top